Clodronate disodium tetrahydrate

Names

[ Name ]:
Clodronate disodium tetrahydrate

[Synonym ]:
Sodium (dichloromethylene)bis[hydrogen (phosphonate)] hydrate (2:1:4)
Phosphonic acid, (dichloromethylene)bis-, sodium salt, hydrate (1:2:4)
Disodium clodronate tetrahydrate
clodronate disodium tetrahydrate
Clodronate Disodium

Biological Activity

[Description]:

Clodronate disodium tetrahydrate (Disodium clodronate tetrahydrate) is first-generation bisphosphonate, with anti-osteoporotic, anti-inflammatory and analgesic effects. Clodronate disodium tetrahydrate is a selective, potent, reversible and Cl- competitive vesicular nucleotide transporter (VNUT) inhibitor, with an IC50 of 15.6 nM. Clodronate disodium tetrahydrate inhibits vesicular ATP release from neurons and reduces chronic neuropathic and inflammatory pain[1][2].

[Related Catalog]:

Signaling Pathways >> Others >> Others

Research Areas >> Inflammation/Immunology

Research Areas >> Neurological Disease

[Target]

vesicular ATP release[1]

[In Vitro]

Clodronate disodium tetrahydrate, a first-generation bisphosphonate, significantly attenuates neuropathic and inflammatory pain unrelated to bone abnormalities via inhibition of VNUT, a key molecule for the initiation of purinergic chemical transmission [1]. Clodronate disodium tetrahydrate is an allosteric modulator of VNUT Cl- dependence [1]. Clodronate disodium tetrahydrate acts as antiresorptive in osteoporosis[2].

[In Vivo]

Clodronate disodium tetrahydrate (10 mg/kg; i.v.) attenuates inflammatory pain via VNUT inhibition[1]. Clodronate disodium tetrahydrate attenuates inflammation via VNUT inhibition [1]. Animal Model: C57BL/6 mice (22-30 g)[1] Dosage: 10 mg/kg Administration: Intravenous injection Result: Attenuated carrageenan- or complete Freund’s adjuvant (CFA)-evoked inflammatory pain.

[References]

[1]. Kato Y, et al. Identification of a vesicular ATP release inhibitor for the treatment of neuropathic and inflammatory pain. Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):E6297-E6305.

[2]. Moriyama Y, et al. Clodronate: A Vesicular ATP Release Blocker. Trends Pharmacol Sci. 2018 Jan;39(1):13-23.

Chemical & Physical Properties

[ Molecular Formula ]:
CH₁₂Cl₂Na₂O₁₀P₂

[ Molecular Weight ]:
360.917

[ Exact Mass ]:
359.892151

[ PSA ]:
177.26000

[ LogP ]:
1.04990

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.